ANXA1 and rheumatoid arthritis: ANXA1 has also been found to be released from RA synovial fibroblasts (RASF) following tumour necrosis factor (TNF)‐a‐mediated activation, and to promote RASF matrix metalloproteinase‐1 secretion [73], known to play a major role in collagen degradation.